Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae. 1999

Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos

The gyrA subgenes of a quinolone-resistant Enterobacter cloacae clinical isolate (ofloxacin MIC, 16 mg/L) and of a control, E. cloacae NCTC 10005 (ofloxacin MIC, 0.03 mg/L), were amplified by polymerase chain reaction (PCR) and sequenced. The resistant isolate had mutations at the codons for amino acids 83, 89 and 90. The first of these mutations led to replacement of serine-83 by tyrosine, whereas the other mutations were silent. Digestion of PCR-amplified DNA fragments with the restriction enzyme HinfI detected mutations at the same site in gyrA in six further quinolone resistant E. cloacae isolates.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
October 1997, The Journal of antimicrobial chemotherapy,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
April 1996, Antimicrobial agents and chemotherapy,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
September 1995, Antimicrobial agents and chemotherapy,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
February 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
January 1998, Microbiology and immunology,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
October 1994, Antimicrobial agents and chemotherapy,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
September 1996, The Journal of antimicrobial chemotherapy,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
November 1990, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
January 1996, Microbial drug resistance (Larchmont, N.Y.),
Christine Dekitsch, and Robert Schein, and Effi Markopulos, and Beatrix Kuen, and Wolfgang Graninger, and Apostolos Georgopoulos
January 2001, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Copied contents to your clipboard!